Results

Total Results: 1,651 records

Showing results for "described".

321. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-interventions-maltreatment-child_research-protocol.pdf
     January 12, 2012 - Additionally, as described earlier, we modified the conceptual framework for the psychosocial interventions … Appropriateness will be determined by the same inclusion and exclusion criteria described in the previous … members of the research team for inclusion or exclusion on the basis of the eligibility criteria described … Risk of Bias of Individual Studies To assess the risk of bias of studies, we will use criteria described … The grades of evidence that can be assigned are described in Table 4.

322. Binge-Eating Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_research-protocol.pdf
     July 21, 2014 - Interventions Pharmacological, behavioral, psychological, or CAM treatments or combinations as described … Control interventions Any active intervention described in the PICOTS criteria, placebo, or usual … Inclusion/exclusion criteria (continued) Criteria Category Inclusion Exclusion Outcomes As described … The appropriateness of those studies will be determined using the methods described above. … As described above, all results will be tracked in an EndNote database.

323. Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
     February 01, 2013 - evidence about how to reduce this potential for bias, we recommend that inclusion criteria be clearly described … Intervention Intervention described as anticoagulants Reviewer must make the decision on which … Outcome Described as effectiveness outcomes Reviewers determine whether specific outcomes are … Setting Described as outpatient Reviewers must decide whether various settings are in fact outpatient … Methods exist to reduce the likelihood of both problems, as described in this chapter.

324. Autism-Adolescents Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
     August 01, 2012 - More research is needed to determine a measure of effect associated with any of the interventions described … • Intervention not clearly described; treatment fidelity and concomitant interventions not reported … not reported within study; inclusion/exclusion criteria not clearly stated; interventions not fully described … comparison group in 2 case series; attrition not always reported and interventions not always fully described … • Attrition and treatment fidelity not reported; randomization method not clearly described; differences

325. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - Peer Reviewer #1 Methods These are well described. … you Peer Reviewer #2 Methods search appears to be have been performed appropriately and is well- described … Thank you Peer Reviewer #1 Results The results section is well described, although as mentioned in … More detail regarding fertility and malignancy as described above would be useful. Thank you. … The methods are well described and results well summarized. The target audience is well defined.

326. Research White Paper_Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governance Toolkit (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-research-depression.pdf
     October 01, 2021 - on the best practices found through the literature, registry websites, and stakeholder interviews described … While these topics are described separately, many of the processes discussed in each section occur in … The steps in this workflow are described further below. 17 Figure 4-1. … These options are described below: • On-demand data download: Registries may store relevant datasets … How is the registry described and/or acknowledged in publications? a.

327. Slide 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/introductory-slides-ahrq-cf-webinar.pdf
     August 27, 2012 - Slide 1 Community Forum Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques August 27, 2012 Community Forum Community Forum Community Forum Vice President for Program Development, Center for Medical Technology Poli…

328. celiac-disease-protocol-140612 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
     June 12, 2014 - will also assess the quality of existing reviews we include as evidence using the AMSTAR13 instrument described … , 2012).11 We will use the QUADAS-2 instrument for studies on test accuracy; domains and items are described … As mentioned above, we will use the AMSTAR instrument,12 described in Table 4 below, to assess the quality … When pooling is not possible, study results will be described narratively, according to comparisons … We will discuss their methods of evaluating the domains described below.

329. Meditation Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
     October 17, 2012 - Academically, these programs have been described as “concentrative” meditation, such as Transcendental … Weight, AE (KQ4)) Figure 1: This figure depicts the key questions within the context of the PICOTS described … A third reviewer will resolve discrepancies Selection Bias: • Was the method of randomization described … We did not fomally consider publication bias in assigning the SOE, we described the results of our … Adverse Events Figure 1: This figure depicts the key questions within the context of the PICOTS described

330. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
     September 01, 2011 - We have described our decisions and tried to make clear the limitations. … Studies are succintly but adequately described, and the descriptions appear to be accurate (for those … The characteristics of the studies are clearly described. The key messages were explicit. … The limitations of the review are described adequately. … Comment Response Ryan Carnahan Executive Summary ES- 1,2 Page 4 in executive summary: As described

331. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - TEP #2 Methods Methods were explicit and well described; i can not comment on the statistical testing … This is explicitly described in the SOE table (Table 5 in the full report). … YES Are the characteristics of the studies clearly described? … YES Are the limitations of the review/studies described adequately? … quantitative differences between comparison to healthy vs. symptomatic Management algorithms are described

332. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
     September 29, 2011 - key questions within the context of the PICO (population, interventions, comparators, and outcomes) described … Data necessary for assessing quality and applicability, as described in the Methods Guide, will also … We will evaluate the quality of individual studies by using the approach described in the Methods Guide … methodological quality, we will apply criteria for each study type derived from the core elements described … Question The strength of evidence for each key question will be assessed by using the approach described

333. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - The characteristics of the included studies are adequately described in the text and appendix tables … The main findings of the review and available evidence are clearly described, and future research needs … For clinical decision- making, nothing really new is described but again this is due to the lack of … referred to is included in our systematic review (CHAMPION trial) and the results are very extensively described … Detailed Analysis For the studies described in detail, its helpful to the reader if the study type,

334. Case-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
     January 01, 2013 - Questions and the populations, interventions, comparators, outcomes, timing, and setting (PICOTS) as described … Our approach is consistent with the methods described by Owens et al.11 to evaluate the body of evidence … Therefore, these factors are described within each section when possible. … Based on the entire range of interventions described in the included studies, the types of patients … Other examples of CM elements that should be explicitly described in future research include: • Training

335. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - It provides definitions for various conditions within the AUD spectrum, described how treatment for … The process for determining the scope is described in the Methods section and in the topic refinement … Just as recruitment methods are described in the Tables, a description of severity would be useful in … Please include this for each paragraph where an outcome's results are described Thank you. … We developed the list of eligible medications as described in the Methods section.

336. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - discrepant outcomes and results between the published and unpublished results, based on our review, described

337. White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
     January 01, 2024 - The first white paper described challenges and practical and methodological considerations encountered … The first white paper7 drew on experience of the first year of the living review8 and described practical … excluded because they evaluated cannabis in patients with multiple sclerosis who were not clearly described … As described in the second white paper, we considered expanding the scope to include multiple sclerosis … for mixed chronic pain; the pain conditions and cannabis products evaluated were generally not well described

338. Suppl-1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/suppl-1-user-guide-to-ocer_130129.pdf
     January 01, 2011 - drawn if one could use a sampling process to obtain an unlimited number of observations.”3 Or, as described … On the “support” A research objective is described as being on the “support” of a research database … CER objective is defined for a patient population with specific characteristics, the objective is described … instrumental variables or “instruments.”7, 14, 23-25 Because of this limitation, IV estimates are described … assumptions that are necessary for estimates of ATT or LATE to be validly applied to the set of patients described

339. Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
     June 17, 2014 - We attempted to identify and summarize transition care for CSHCNs as it is described in the published … Rosen described the focus of care in a paediatric setting as being on growth and development, whereas … Reviewer 2 (TEP) Methods The methods are well described. We appreciate your feedback. … Well-described. Thank you. … Reviewer 7 (TEP) Methods The methods are clearly described and reflect the state of knowledge, current

340. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - Disorders and Stroke (NINCDS) and the Alzheimer’s Disease and Related Disorders Association (ADRDA) described … the review based on the PICOTS framework outlined above and the study-specific inclusion criteria described … processes, narrow eligibility criteria, and patient and intervention characteristics different than those described … studies.18 These applicability issues are present in the synthesis frameworks and sensitivity analyses described